Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
US Department of Justice
Mallinckrodt
Boehringer Ingelheim
Fish and Richardson
QuintilesIMS
Healthtrust
Teva
Baxter
Accenture

Generated: October 21, 2017

DrugPatentWatch Database Preview

Tersera Therap Company Profile

« Back to Dashboard

What is the competitive landscape for TERSERA THERAP, and when can generic versions of TERSERA THERAP drugs launch?

TERSERA THERAP has three approved drugs.

There are three US patents protecting TERSERA THERAP drugs.

There are forty-eight patent family members on TERSERA THERAP drugs in thirty-three countries.

Summary for Applicant: Tersera Therap

International Patents:48
US Patents:3
Tradenames:2
Ingredients:2
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ERGOMAR
ergotamine tartrate
TABLET;SUBLINGUAL087693-001Feb 24, 1983RXNoYes► Subscribe► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tersera Therap

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tersera Therap Drugs

Country Document Number Estimated Expiration
Russian Federation2002124770► Subscribe
Bulgaria65506► Subscribe
Russian Federation2234341► Subscribe
Hong Kong1049454► Subscribe
Japan4208466► Subscribe
China1202875► Subscribe
Cyprus1107998► Subscribe
Poland357237► Subscribe
Iceland2464► Subscribe
Spain2273803► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Teva
Baxter
Colorcon
McKinsey
Medtronic
Federal Trade Commission
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot